vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and TELOS CORP (TLS). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $46.8M, roughly 1.8× TELOS CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -34.9%, a 57.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 77.4%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $8.0M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 25.7%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

FDMT vs TLS — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.8× larger
FDMT
$85.1M
$46.8M
TLS
Growing faster (revenue YoY)
FDMT
FDMT
+8508822.6% gap
FDMT
8508900.0%
77.4%
TLS
Higher net margin
FDMT
FDMT
57.7% more per $
FDMT
22.8%
-34.9%
TLS
More free cash flow
FDMT
FDMT
$20.5M more FCF
FDMT
$28.5M
$8.0M
TLS
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
25.7%
TLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
TLS
TLS
Revenue
$85.1M
$46.8M
Net Profit
$19.4M
$-16.3M
Gross Margin
35.0%
Operating Margin
17.3%
-39.6%
Net Margin
22.8%
-34.9%
Revenue YoY
8508900.0%
77.4%
Net Profit YoY
139.1%
-74.8%
EPS (diluted)
$0.43
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
TLS
TLS
Q4 25
$85.1M
$46.8M
Q3 25
$90.0K
$51.4M
Q2 25
$15.0K
$36.0M
Q1 25
$14.0K
$30.6M
Q4 24
$1.0K
$26.4M
Q3 24
$3.0K
$23.8M
Q2 24
$5.0K
$28.5M
Q1 24
$28.0K
$29.6M
Net Profit
FDMT
FDMT
TLS
TLS
Q4 25
$19.4M
$-16.3M
Q3 25
$-56.9M
$-2.1M
Q2 25
$-54.7M
$-9.5M
Q1 25
$-48.0M
$-8.6M
Q4 24
$-9.3M
Q3 24
$-43.8M
$-28.1M
Q2 24
$-35.0M
$-7.8M
Q1 24
$-32.4M
$-7.4M
Gross Margin
FDMT
FDMT
TLS
TLS
Q4 25
35.0%
Q3 25
39.9%
Q2 25
33.2%
Q1 25
39.8%
Q4 24
40.3%
Q3 24
13.2%
Q2 24
34.1%
Q1 24
37.0%
Operating Margin
FDMT
FDMT
TLS
TLS
Q4 25
17.3%
-39.6%
Q3 25
-67983.3%
-4.8%
Q2 25
-396373.3%
-27.5%
Q1 25
-383007.1%
-29.5%
Q4 24
-37.6%
Q3 24
-1704400.0%
-121.4%
Q2 24
-849120.0%
-30.3%
Q1 24
-136200.0%
-28.5%
Net Margin
FDMT
FDMT
TLS
TLS
Q4 25
22.8%
-34.9%
Q3 25
-63195.6%
-4.1%
Q2 25
-364386.7%
-26.5%
Q1 25
-342657.1%
-28.1%
Q4 24
-35.4%
Q3 24
-1461433.3%
-118.0%
Q2 24
-699060.0%
-27.2%
Q1 24
-115717.9%
-24.9%
EPS (diluted)
FDMT
FDMT
TLS
TLS
Q4 25
$0.43
$-0.22
Q3 25
$-1.01
$-0.03
Q2 25
$-0.98
$-0.13
Q1 25
$-0.86
$-0.12
Q4 24
$-0.13
Q3 24
$-0.79
$-0.39
Q2 24
$-0.63
$-0.11
Q1 24
$-0.66
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$402.7M
$53.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$96.0M
Total Assets
$566.7M
$139.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
TLS
TLS
Q4 25
$402.7M
$53.2M
Q3 25
$305.1M
$59.0M
Q2 25
$293.2M
$57.0M
Q1 25
$321.4M
$57.8M
Q4 24
$424.9M
$54.6M
Q3 24
$501.9M
$69.8M
Q2 24
$541.9M
$80.1M
Q1 24
$525.9M
$93.9M
Stockholders' Equity
FDMT
FDMT
TLS
TLS
Q4 25
$505.7M
$96.0M
Q3 25
$369.0M
$119.7M
Q2 25
$420.9M
$118.4M
Q1 25
$469.7M
$126.1M
Q4 24
$510.6M
$127.1M
Q3 24
$552.9M
$129.5M
Q2 24
$588.3M
$149.1M
Q1 24
$600.6M
$154.4M
Total Assets
FDMT
FDMT
TLS
TLS
Q4 25
$566.7M
$139.9M
Q3 25
$424.0M
$164.3M
Q2 25
$473.6M
$165.0M
Q1 25
$515.7M
$158.1M
Q4 24
$560.4M
$158.2M
Q3 24
$604.0M
$166.3M
Q2 24
$620.1M
$182.4M
Q1 24
$629.9M
$195.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
TLS
TLS
Operating Cash FlowLast quarter
$28.6M
$8.0M
Free Cash FlowOCF − Capex
$28.5M
$8.0M
FCF MarginFCF / Revenue
33.5%
17.0%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
TLS
TLS
Q4 25
$28.6M
$8.0M
Q3 25
$-46.5M
$9.1M
Q2 25
$-43.4M
$7.0M
Q1 25
$-47.8M
$6.1M
Q4 24
$-134.6M
$-10.5M
Q3 24
$-29.4M
$-7.1M
Q2 24
$-30.2M
$-8.0M
Q1 24
$-29.1M
$-350.0K
Free Cash Flow
FDMT
FDMT
TLS
TLS
Q4 25
$28.5M
$8.0M
Q3 25
$-46.6M
$8.7M
Q2 25
$-43.4M
$6.8M
Q1 25
$-48.4M
$6.0M
Q4 24
$-138.4M
$-12.4M
Q3 24
$-31.2M
$-7.1M
Q2 24
$-30.6M
$-8.2M
Q1 24
$-29.8M
$-447.0K
FCF Margin
FDMT
FDMT
TLS
TLS
Q4 25
33.5%
17.0%
Q3 25
-51765.6%
16.9%
Q2 25
-289620.0%
19.0%
Q1 25
-345635.7%
19.5%
Q4 24
-13837100.0%
-47.0%
Q3 24
-1038966.7%
-30.0%
Q2 24
-611840.0%
-28.9%
Q1 24
-106421.4%
-1.5%
Capex Intensity
FDMT
FDMT
TLS
TLS
Q4 25
0.1%
0.1%
Q3 25
101.1%
0.9%
Q2 25
440.0%
0.4%
Q1 25
4507.1%
0.4%
Q4 24
378600.0%
7.1%
Q3 24
59266.7%
0.2%
Q2 24
6980.0%
0.8%
Q1 24
2535.7%
0.3%
Cash Conversion
FDMT
FDMT
TLS
TLS
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons